PB2030: CLINICAL, LABORATORY PROFILE, TREATMENT AND OUTCOME OF PRIMARY AMYLOIDOSIS IN THE ERA OF NOVEL AGENTS: AN EXPERIENCE FROM A TERTIARY CARE HOSPITAL IN INDIA

por Sivaprakasam, Y., Kotwal, J., Saraf, A., Gupta, P., Gupta, N.
Publicado 2022

PfMORC protein regulates chromatin accessibility and transcriptional repression in the human malaria parasite, P. falciparum

por Chahine, Z, Gupta, M, Lenz, T, Hollin, T, Abel, S, Banks, CAS, Saraf, A, Prudhomme, J, Florens, L, Le Roch, KG
Publicado 2023

IDF21-0186 Real-world effectiveness of Diabefly digital therapeutics program for glycemic control during COVID-19 pandemic in India

por Verma, R., Ranadive, R., Kalra, S., Lathia, T., Saraf, A., Thakur, S., Sarwate, A., Lakhani, O., Das, R., Shenoy, M.T., Joshi, S., Singal, A.
Publicado 2022

BRK phosphorylates SMAD4 for proteasomal degradation and inhibits tumor suppressor FRK to control SNAIL, SLUG, and metastatic potential

por Miah, S., Banks, C. A. S., Ogunbolude, Y., Bagu, E. T., Berg, J. M., Saraf, A., Tettey, T. T., Hattem, G., Dayebgadoh, G., Kempf, C. G., Sardiu, M., Napper, S., Florens, L., Lukong, K. E., Washburn, M. P.
Publicado 2019